Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Altering Bicarbonate Delivery in Hemodialysis
NCT02639624Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Jan 2016
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by NYU Langone Health. Primary endpoint: Change in the amount of Indoxyl Sulfate level in the first half of dialysis as compared to controls at 210 Minutes. Planned start Jan 2016; status: withdrawn.
Beyond the preview
Go deeper on NCT02639624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639624.